Cargando…
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts
Intratumoral (IT) administration of submicron particle docetaxel (NanoDoce(®), NanOlogy LLC, Fort Worth, TX, USA) and its efficacy against genitourinary-oncologic xenografts in rats and mice, xenograft-site docetaxel concentrations and immune-cell infiltration were studied. IT-NanoDoce(®), IV-doceta...
Autores principales: | Maulhardt, Holly A., Hylle, Lauren, Frost, Michael V., Tornio, Ashley, Dafoe, Sara, Drummond, Leanne, Quinn, David I., Kamat, Ashish M., diZerega, Gere S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520999/ https://www.ncbi.nlm.nih.gov/pubmed/31022918 http://dx.doi.org/10.3390/cancers11040577 |
Ejemplares similares
-
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions
por: Maulhardt, Holly, et al.
Publicado: (2021) -
Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood
por: Maulhardt, Holly A., et al.
Publicado: (2020) -
Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies
por: Maulhardt, Holly, et al.
Publicado: (2022) -
Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac(®)) in a Rodent Model
por: Verco, James, et al.
Publicado: (2019) -
Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies
por: Verco, Shelagh, et al.
Publicado: (2020)